Clinical isolates of Staphylococcus aureus have been previously classified into eight types on the basis of their capsular polysaccharide. The high prevalence of the type 8 capsular polysaccharide among bacteremic isolates suggests the importance of this capsular antigen in staphylococcal disease. The capsular polysaccharide was purified from extracts of three clinical isolates of S. aureus type 8 of different geographic and temperal origin by ion-exchange chromatography and gel filtration. Gas chromatography, gas chromatography-mass spectrometry, and 13C-nuclear magnetic resonance showed that the type 8 capsular polysaccharide is composed of O-acetyl groups, N-acetylfucosamine, and an aminouronic acid similar to N-acetylgalactosaminouronic acid.
Infections due to Staphylococcus aureus remain a major cause of morbidity and mortality despite prophylactic actions and extensive use of antibiotics. This organism elaborates a wide range of intracellular or extracellular products, including toxins and enzymes which have been correlated with various diseases. However, none of these products have been related to the invasive properties of this organism.
The involvement of capsular polysaccharides (CPs) in the invasiveness of many bacteria, including Streptococcus pneumoniae, Klebsiella pneumoniae, Haemophilus influenzae type b, Neisseria meningitidis, Escherichia coli, and group B Streptococcus agalactiae, is well established (24) . CPs of S. aureus have been demonstrated and partially characterized in several mucoid strains designated Smith (8, 10, 11, 21, 29) , RLM (3, 20, (35) (36) (37) (38) (39) 41) , M (17, 18, 22, 28) , T (40), K93-M (10), 7007 (12) , D (16) , and Mardi (14, 15). However, these encapsulated strains were rarely isolated from patients with invasive staphylococcus diseases (13) .
Recent evidence indicates that S. aureus isolates from patients with bacteremia possess type-specific CPs which are different from those reported (13) . An initial classification identified eight types representing about 70% of the isolates from patients with bacteremia (13) . A preliminary survey of 58 strains isolated from hospitalized patients showed the prevalence of type 8 CP (13) . This report describes the purification and the immunological and chemical characterization of the type 8 CP of S.
aureus.
MATERIALS AND METHODS
S. aureus strains. Strains BeckerT (prototype 8) (13) supplied by the Centers for Disease Control, Atlanta, Ga. These four strains were identified as type 8 with a rabbit antitype 8 serum. Non-encapsulated strains 32 and 57 were isolated from healthy carriers. All strains were stored lyophilized in milk.
Growth of bacteria. Bacteria were cultivated on Columbia blood agar base (no. 0792; Difco Laboratories, Detroit, Mich.) overnight at 37°C under 5% CO2. The cultures were checked for type 8 CPs as follows. A few colonies were suspended in a 1.5-ml polypropylene microfuge tube containing 0.2 ml of phosphate-buffered saline (PBS) (pH 7.4) and autoclaved at 121°C for 20 min or treated with lysostaphin (no. L 8255; Sigma Chemical Company, St. Louis, Mo.) (0.1 mg of PBS per ml, 1 h at 37°C). After centrifugation, type 8 CP was detected in the supernatant by capillary precipitation against a rabbit anti-type 8 serum.
Bacterial cells for extractions of CP were grown on either Columbia agar or in broth medium. A cell suspension obtained from one petri plate was used to inoculate 1 New Zealand white rabbits were immunized three times a week for 4 weeks with increasing amounts (0.1 to 0.4 ml) of the bacterial suspension. The first immunization dose was given subcutaneously, and each subsequent injection was given intravenously. The animals were bled after the second, third, and fourth weeks of immunization. Sera were tested by the direct cell agglutination test as follows: twofold dilutions of the test serum were made in PBS to 0.25 ml. To each dilution of serum was added 0.25 ml of bacterial suspension, and the agglutination was read after 4 h at 37°C and overnight at 4°C. When agglutinin titers were 1,280 or more, the rabbit was exsanguinated.
The serum was absorbed with trypsinized non-encapsulated strain 57. An overnight culture of strain 57 in 1 liter of tryptic soy broth (Difco) was killed by heating at 70°C for 1 h. The bacteria were washed three times and suspended in 100 ml of PBS. The cells were treated with trypsin (1 mg/ml of cell suspension) and a few drops of chloroform overnight (6) .
The NaOCl-amylose-potassium iodide method of Sandford et al. (2, 25, 26) was used to detect amino sugars in column fractions. To 0.2 ml of sample was added 0.4 ml of NaHCO3-NaOCl reagent (0.025 M NaHCO3 containing 50 ml of NaOCl solution [4 to 6%] per liter; pH adjusted to 9 with 2 N Na2CO3). After 2 h at room temperature, 0. Fig. 1 . The second peak contained type 8 CP, and the third peak contained teichoic acid. Most of the protein was eluted in the first peak, and nucleic acids were eluted in the fourth peak. Although the NaOClamylose-potassitum iodide method detects amino sugar and protein, peaks II and III were presumed to be due to amino sugar-containing materials. Type 8 CP was finally purified by gel filtration (Fig. 2) Only one monosaccharide was detected by gas chromatography in acid hydrolysates from intact type 8 CP (Fig. 4) . This monosaccharide elutes with the same retention time and gives the same mass fragmentation pattern as N-acetylfucosamine. The fucosamine in pneumococcal type 4 polysaccharide hydrolysate was used as a reference. The chromatogram in Fig. 4 illustrates that type 8 CP is chemically distinct from teichoic acid isolated during the same preparation ( Fig. 1, peak III) , since type 8 CP does not contain Nacetylglucosamine.
An additional amino sugar eluting similarly to N-acetylgalactosamine was detected in the carboxyl-reduced type 8 CP. This suggests that the intact polysaccharide contains Nacetylgalactosaminouronic acid, since carboxyl reduction of this uronic acid would give N-acetylgalactosamine. The identification of this uronic acid was not further investigated.
A 13C NMR spectrum of type 8 CP is presented in Fig. 5 .
The presence of N-acetylhexosamine was confirmed by the characteristic resonances for C-2 at 55. 5 (Fig.  6 ). These preparations did not react with anti-teichoic acid serum. Teichoic acid isolated during the same purification ( Fig. 1, peak III) 23 ) which was widespread in many parts of the world from the mid-1950s to the early 1960s. These three strains have the same type CP as the type 8 prototype strain BeckerT.
These experiments describe the purification of a CP from clinical isolates of S. aureus. This polysaccharide, like that of the M and Smith strains (designated types 1 and 2), and the CPs of E. coli and H. influenzae confer resistance to complement-mediated opsonophagocytosis by leukocytes (13, 15; unpublished results) . Although the Smith, RML, and M strains are encapsulated, they are not representative of the more common isolates of S. aureus. The state of encapsulation of the strains used in this study could not be detected by visual examination of colonies or by the Quellung reaction. The presence of the type 8 CP could be detected by agglutination with specific sera and a lack of agglutination with anti-teichoic acid sera at dilutions less than 1:20 (unpublished data). However, cells can be agglutinated with anti-teichoic acid antibodies after being boiled at pH 2. Encapsulation of single colonies could be distinguished by immunological detection of the type 8 CP released from the cells either by autoclaving or by treatment with lysostaphin. Since this method can be done with only one colony, it also may be applied to the typing of clinical isolates.
CPs have been purified from the supernatants of cultures of E. coli (32) , H. influenzae (27) 45, 1984 Although our analysis shows that type 8 CP is a distinct polymer of S. aureus, the chemical composition of type 8 CP is similar to that reported for other S. aureus CPs. Type 8 CP contains N-acetylfucosamine and an N-acetylhexosaminouronic acid. N-acetylfucosamine also is present in S. aureus type 1 (14, 16, 22) and type 4 (12, 13, 40) CPs. An Nacetylhexosaminouronic acid is present in type 1 (13, 14, 22) , type 2 (8-10, 28), and type 4 (12, 13, 40) CPs. However, a comparison of the NMR spectra for type 8 CP and that reported for the M strain (type 1) indicates that these are distinct polymers (22) . The composition of these polymers is similar to that of teichuronic acids produced by other grampositive bacteria (34) .
The availability of purified type 8 CP will allow further study of its chemical structure and the preparation of immunological reagents for the detection of antibodies and antigens in humans and animals. These reagents should be useful in achieving a better understanding of staphylococcal disease.
